Rutherford Robert B
University of Colorado School of Medicine, Aurora, CO, USA.
Semin Vasc Surg. 2008 Sep;21(3):124-31. doi: 10.1053/j.semvascsurg.2008.05.005.
There are three choices for management of abdominal aortic aneurysms (AAA), ie, endovascular repair (EVAR), open repair (OR), and continuing surveillance (OBS). The treating physician must weigh the risk of no intervention, in terms of ultimate death from rupture, against the more immediate risk associated with either form of repair, considering in the process those risk factors that directly or indirectly relate to outcome. These risk factors include AAA size and the patient's comorbidities, age, gender, and AAA anatomy, as well as the skills and experience of the treating physicians and the health care environment in which the patient is treated. While individualization is clearly required, a generalizable platform for decision-making derived from past trials and other pertinent observational studies is also useful. This article attempts to present pertinent background information and develop it into generally applicable guidelines.
腹主动脉瘤(AAA)的治疗有三种选择,即血管腔内修复术(EVAR)、开放修复术(OR)和持续监测(OBS)。治疗医师必须权衡不干预的风险(即最终因破裂而死亡)与两种修复方式各自相关的更直接风险,在此过程中要考虑那些直接或间接与预后相关的风险因素。这些风险因素包括腹主动脉瘤大小、患者的合并症、年龄、性别、腹主动脉瘤解剖结构,以及治疗医师的技能和经验,还有患者接受治疗的医疗环境。虽然显然需要个体化,但从过去的试验和其他相关观察性研究中得出的可推广决策平台也很有用。本文试图呈现相关背景信息并将其发展为普遍适用的指南。